Qureight has appointed Steven Bishop as chief medical officer, marking [...]

Syncromune has appointed Stephen Dale as chief medical officer, strengthening [...]

Minovia Therapeutics has been granted two new US patents covering [...]

Bicara Therapeutics has selected 1500 mg of ficerafusp alfa as [...]

Merck has announced that the US Food and Drug Administration [...]

Cellares has secured FDA clearance of an IND amendment allowing [...]

Shilpa Medicare Limited is targeting US approval for its Ondansetron [...]

Trenchant BioSystems has released internal and external data confirming its [...]

CERo Therapeutics has reported early clinical findings from its ongoing [...]

Breast cancer remained the world’s most studied disease for the [...]